Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-054799)

Filing Details

Accession Number:: 0001209191-21-054799
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-03 17:00:16
Reporting Period:: 2021-09-01

Accepted Time:: 2021-09-03 17:00:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1812025	Justin Burgess	C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-01	20,000	$3.81	23,721	No	4	M	Direct
Common Stock	Disposition	2021-09-01	20,000	$20.00	3,721	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-01	20,000	$0.00	20,000	$3.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-06-13	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2021.
All shares were sold at $20.00.
All of the shares subject to the option vested and become fully-exercisable on August 13, 2020.
Not applicable.